Haploidentical hematopoietic cell transplantation for mycosis fungoides/ Sezary syndrome using reduced intensity conditioning after brentuximab therapy discontinuation: advantages of an outpatient program in the times of COVID-19
Hematol., Transfus. Cell Ther. (Impr.); 43 (3), 2021
Publication year: 2021